Home > Keywords > Thématique > Agenda

Agenda

Articles

  • Vect-Horus Nominated for the 2024 Biotech Trophy Award, Organized by France Biotech
    21 March 2024, by Emmanuelle BETTENDORF

    Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced it has been nominated for the 2024 Biotech Trophy award, organized by the France Biotech industry association.
    The award recognizes a biotech company which has distinguished itself in the past two years by particularly remarkable advances in R&D, operational development, partnerships or (…)

  • Meet Vect-Horus at BIO Japan
    3 September 2019, by Elodie DORMES

    Dr Jamal TEMSAMANI, Drug Development and Corporate Director will attend BIO Japan from October 9–11, 2019
    If you are interested to meet, please use the B2B Partnering system.

  • Vect-Horus confirmed to attend BioPharm America 2017
    28 January 2019, by Jonathan NOWAK

    26-27/09/2017
    Boston USA
    ebdgroup.knect365.com/biopharm-america/

  • Vect-Horus will be attending the EANM’19 Congress in Barcelona
    3 September 2019, by Elodie DORMES

    Cedric MALICET PhD, Oncology Project Manager and Elodie DORMES, Business Development Manager will attend EANM from 12-16 October, 2019 in Barcelona to discuss Peptide Receptor Radionuclide Therapy strategy and partnered Vect-Horus’ products.

  • Meet Vect-Horus at BIOTECH SHOWCASE, San Francisco, January 8-10, 2024
    20 December 2023, by Emmanuelle BETTENDORF

    From January 8 to 10, Emmanuelle Bettendorf will participate in the #BiotechShowcase at #JPM24 and will be available to meet with you on partnership opportunities.

  • Meet Vect-Horus at BIO Spring Barcelona
    28 January 2019, by Jonathan NOWAK

    March 20-22 // Barcelona, SPAIN

  • Meet Vect-Horus at BIO International in San Diego June 14-18, 2022
    30 May 2022, by Elodie DORMES

    Elodie DORMES, Sr Business Development Manager, will attend Bio International Convention.

  • Meet Vect-Horus at BIO Spring Vienna
    18 January 2019, by Jonathan NOWAK

    VECT-HORUS will attend BIO Europe from March 25–26, 2019
    If you are interested to meet, please use the B2B Partnering system.
    https://ebdgroup.knect365.com/bioeu...

  • BIO International Convention in BOSTON, MA
    28 January 2019, by Jonathan NOWAK

    The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.
    VECT-HORUS’ business model is to make its technology platform available to pharmaceutical and biotech partners to transport their drug to the brain and other organs using feasibility studies. Subsequently, the Company will license-out its technology. VECT-HORUS is also building proprietary (…)

  • Vect-Horus will be attending the EANM’18 Congress in Düsseldorf
    28 January 2019, by Jonathan NOWAK

    VECT-HORUS will present a poster on its proprietary technology platform, VECTrans®, for the targeting and delivery of imaging or therapeutic agents to tumors.
    Please come and meet Cedric MALICET PhD, Oncology Project Manager.